drugset / Trial / NCT02517866
Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of azilsartan medoxomil (AZM) in Asian adult participants with both essential hypertension and type 2 diabetes.
Timeline
- Start
- 2015-07-13
- Primary completion
- 2016-11-15
- Completion
- 2016-11-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azilsartan medoxomil | Other / unclassified | 40 mg | Oral |
| Subject | Azilsartan medoxomil | Other / unclassified | 80 mg | Oral |